Answers are grounded in this paper and cite their sources.
A solvothermal strategy and a mutual oxidation–reduction approach are used to fabricate ruthenium oxide (RuO2)-based nanocomposites, including RuO2 and RuO2–gold (Au) nanoparticles supported on commercial carbon supports (RuO2/C and RuO2–Au/C nanocomposites). The novelty of this work lies in the synthetic approaches, which are based on a thermal decomposition of metal complexes formed by RuCl3 and dodecylamine at room temperature (for RuO2/C) and the mutual oxidation–reduction phenomenon between RuCl3 and HAuCl4 at elevated temperature (for RuO2–Au/C) in the presence of carbon supports. In particular, the as-prepared RuO2/C and RuO2–Au/C nanocomposites for supercapacitors adopting the H2SO4 electrolyte exhibit high specific capacitances of 537.7 F g−1 and 558.2 F g−1, respectively, at a current density of 50 mA g−1. The specific capacitance reaches 350.1 F g−1 for the RuO2/C nanocomposites and 478.5 F g−1 for RuO2–Au/C nanocomposites at a current density of 200 mA g−1 with good cycling stability. The comparison of the electrochemical measurements of RuO2/C and RuO2–Au/C nanocomposites demonstrates that the presence of Au in the nanocomposites is favorable for the enhancement in capacitive behavior of RuO2.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: